Abstract:
Objective To explore the role and the signaling pathways of autophagy-related gene 5 (ATG5) in hepatocellular carcinoma (HCC).
Methods The Cancer Genome Atlas (TCGA) database was used to investigate the expression of ATG5 in HCC tissues and differential analysis in its subgroups. Western blotting was performed to clarify its expression in HCC cell lines. Cell Counting Kit-8, wound healing assay, and Transwell assay were employed to unveil the function of ATG5 in HCCLM3 and MHCC97-H cells. RNA Sequencing and differentially expressed genes analysis were performed to discover the relevant signaling pathways.
Results TCGA database showed that the mRNA expression of ATG5 was significantly higher in HCC tissues compared with that in normal liver tissues (P < 0.000 1), and higher expression in patients at stage 3 than those at stage 1 (P=0.013). Furthermore, its expression was higher in patients with p53 mutation (P < 0.000 1). Western blotting results showed that the levels of ATG5 were significantly higher in all tested HCC cell lines than L02. Knockdown of ATG5 was found to inhibits HCC cell proliferation, migration, and invasion, and it was also revealed to affect the expression of p53-related signaling pathway, cell cycle and autophagy-related pathway.
Conclusions ATG5 downregulation inhibited the function of HCC cells and promoted HCC progression by affecting the p53 signaling pathway.